Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Asset Utilization Ratio (2018 - 2026)

Catalyst Pharmaceuticals filings provide 9 years of Asset Utilization Ratio readings, the most recent being 0.53 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio fell 12.71% to 0.53 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.53, a 12.71% decrease, with the full-year FY2025 number at 0.6, down 19.05% from a year prior.
  • Asset Utilization Ratio hit 0.53 in Q1 2026 for Catalyst Pharmaceuticals, down from 0.55 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.9 in Q4 2023 to a low of 0.53 in Q1 2026.
  • Median Asset Utilization Ratio over the past 5 years was 0.63 (2022), compared with a mean of 0.65.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 49.16% in 2023 and later plummeted 32.81% in 2024.
  • Catalyst Pharmaceuticals' Asset Utilization Ratio stood at 0.6 in 2022, then skyrocketed by 49.16% to 0.9 in 2023, then plummeted by 32.81% to 0.61 in 2024, then dropped by 9.79% to 0.55 in 2025, then dropped by 2.97% to 0.53 in 2026.
  • The last three reported values for Asset Utilization Ratio were 0.53 (Q1 2026), 0.55 (Q4 2025), and 0.57 (Q3 2025) per Business Quant data.